Double-tailed perfluoroalkylated glycolipids as components for drug delivery and targeting systems. Preliminary biocompatibility results.
Vesicles are being investigated as drug carriers, especially for enhancing the therapeutic effectiveness of the drug while minimizing its side effects. Drug targeting can be achieved if there is a specific recognition of the vesicle's outer wall by specific cells. With these objectives in mind new glycolipids fitted with fluorinated, hydrogenated or mixed, single and double-tails, containing either a gluco- or a galactopyranose residue in their hydrophilic head, were synthesized and their ability to achieve self-organized supramolecular systems was assessed. Replacement of hydrogen by fluorine in these glycolipids was found to enhance biological tolerance. Thus, a fluorinated single-tailed glycolipid displayed no action on red blood cells at concentrations as high as 50 g/l while its hydrogenated analog was hemolytic at 5 g/l. 100% of survival was obtained one month after intravenous or intraperitoneal injection into mice of isotonic dispersions of single and double-tailed glycolipids at a dose of 500 mg/kg. These glycolipids were innocuous on Namalva cell cultures at a concentration of 0.1 g/l.
Unité de Chimie Moléculaire, associée au CNRS, Université de Nice-Sophia Antipolis, France.
L
L
Zarif
J G
JG
Riess
B
B
Pucci
C
C
Guedj
A A
AA
Pavia
D000478:Alkylation; D000818:Animals; D002478:Cells, Cultured; D004337:Drug Carriers; D016503:Drug Delivery Systems; D005466:Fluorocarbons / Q000737:chemistry*; D006017:Glycolipids / Q000737:chemistry*; D006801:Humans; D008422:Materials Testing; D051379:Mice; D012995:Solubility; D013329:Structure-Activity Relationship; D014867:Water / Q000737:chemistry
D004337:Drug Carriers; D005466:Fluorocarbons; D006017:Glycolipids; D014867:Water